Large-scale testing (Phase 3)Study completedNCT02013609
What this trial is testing
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
Who this might be right for
MDD
Otsuka Pharmaceutical Development & Commercialization, Inc. 48